(1)
Rajlaxmi, T.; SS, G.; CM, I. STUDY OF HbA1c AS A BIOMARKER IN DYSLIPIDEMIA AND ATHEROGENICITY IN TYPE 2 DIABETES MELLITUS. IJCBR 2015, 1, 5-11.